A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Condition: Opioid Use Disorder Interventions: Drug: ASP8062; Drug: Placebo ASP8062; Drug: buprenorphine/naloxone Sponsor: Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 30, 2021 Category: Research Source Type: clinical trials